Evolving pneumococcal epidemiology and vaccine impact in the Netherlands, 2004–2024: Carriage and invasive disease
This study shows stabilized pneumococcal carriage from 2018 to 2023 with low invasive disease potential for common serotypes, except for serotype 19A. However, rising IPD incidence from other non-vaccine serotypes highlights the need for higher-valency vaccines. The newly introduced PCV15 covers 58% of IPD cases, while PCV20 could cover 73%.
Authors
- Marianne A. van Houten
- Paul Badoux (ORCID: https://orcid.org/0000-0001-7185-8205)
- Alienke J. Wijmenga‐Monsuur (ORCID: https://orcid.org/0000-0001-5663-860X)
- Nina M. van Sorge (ORCID: https://orcid.org/0000-0002-2695-5863)
- Rob Mariman (ORCID: https://orcid.org/0000-0001-6405-1091)
- Nynke Y. Rots (ORCID: https://orcid.org/0000-0002-7170-7826)
- Krzysztof Trzciński (ORCID: https://orcid.org/0000-0002-5433-8846)
- Anneke Steens (ORCID: https://orcid.org/0000-0002-7474-1149)
- Debbie Smit
- Maurits T Wulffraat
- Nelleke G van de Weijer
Institutions
- University Medical Center Utrecht (NL)
- Spaarne Ziekenhuis (NL)
- National Institute for Public Health and the Environment (NL)
- Amsterdam University Medical Centers (NL)
- Wilhelmina Children's Hospital (NL)
- Spaarne Gasthuis (NL)
Publication Details
- Journal
- Journal of Infection
- Published
- 2025-11-16
- DOI
- https://doi.org/10.1016/j.jinf.2025.106658
- Citations
- 1
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Ministerie van Volksgezondheid, Welzijn en Sport
- Rijksinstituut voor Volksgezondheid en Milieu